Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Alves

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Ebiomedicine|May 30, 2025
Impact of Y chromosome loss on the risk of Parkinson's disease and progressionJunhao Wang, Xinyi Chen, Wenxuan Du, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's diseaseManuela Mx Tan, Hirotaka Iwaki, Sara Bandres-Ciga, et al.
Journal of Parkinson'S Disease|May 24, 2020
Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's DiseaseDanique L M Radder, Jorik Nonnekes, Marlies van Nimwegen, et al.
Clinical Parkinsonism & Related Disorders|January 21, 2026
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleGuido Alves, Yvonne Stavland Sørenes, Veslemøy Hamre Frantzen, et al.
Movement Disorders Clinical Practice|June 19, 2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease DementiaMaria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, et al.
Brain : a Journal of Neurology|November 7, 2022
Mitochondrial haplogroups and cognitive progression in Parkinson's diseaseGanqiang Liu, Chunming Ni, Jiamin Zhan, et al.
Nature Genetics|May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's diseaseGanqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Neurology. Genetics|August 13, 2019
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Ebiomedicine|May 30, 2025
Impact of Y chromosome loss on the risk of Parkinson's disease and progressionJunhao Wang, Xinyi Chen, Wenxuan Du, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's diseaseManuela Mx Tan, Hirotaka Iwaki, Sara Bandres-Ciga, et al.
Journal of Parkinson'S Disease|May 24, 2020
Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's DiseaseDanique L M Radder, Jorik Nonnekes, Marlies van Nimwegen, et al.
Clinical Parkinsonism & Related Disorders|January 21, 2026
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleGuido Alves, Yvonne Stavland Sørenes, Veslemøy Hamre Frantzen, et al.
Movement Disorders Clinical Practice|June 19, 2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease DementiaMaria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, et al.
Brain : a Journal of Neurology|November 7, 2022
Mitochondrial haplogroups and cognitive progression in Parkinson's diseaseGanqiang Liu, Chunming Ni, Jiamin Zhan, et al.
Nature Genetics|May 7, 2021
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's diseaseGanqiang Liu, Jiajie Peng, Zhixiang Liao, et al.
NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
Neurology. Genetics|August 13, 2019
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Pageof 12